No image

oncoReveal CDx Box 3

HDA-LC-2001-48-3 · Pillar Biosciences, Inc.

oncoReveal CDx Box 3 of 4. This box contains Purification Beads.

Details

Device typeColorectal cancer genotyping IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to determine multiple genotypes associated with colorectal cancer, which may include BRAF, KRAS, APC, NRAS, PIK3CA, and/or CTNNB1 gene mutations, using a nucleic acid technique (NAT). It may be used to select treatment options and/or monitor the response to cancer therapy.

FDA categoryNext Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System

Device ID00860001218244

Catalog numberHDA-LC-2001-48-3

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
Oncomine™ Dx Target TestLife Technologies CorporationMultiple tissue-associated protein/tumour marker IVD, reagent	A32441	Life Technologies Corporation	Multiple tissue-associated protein/tumour marker IVD, reagent
PGDx elio™ serverPersonal Genome Diagnostics Inc.Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	B-01-20800	Personal Genome Diagnostics Inc.	Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
PGDx elio™ serverPersonal Genome Diagnostics Inc.Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	B-01-40800	Personal Genome Diagnostics Inc.	Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
cobas® EGFR Mutation Test v2Roche Molecular Systems, Inc.Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	2.0	Roche Molecular Systems, Inc.	Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)